| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/30/2004 | CA2519084A1 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/29/2004 | EP1462111A1 Composition for inducing immunotolerance |
| 09/29/2004 | EP1462109A1 Hemostatic, emollient and lubricating preparations containing pork fat extract (lard) |
| 09/29/2004 | EP1461441A1 Flavivirus vaccine delivery system |
| 09/29/2004 | EP1461440A2 Cultured cells from pancreatic islets |
| 09/29/2004 | EP1461427A2 Methods for targeted expression of therapeutic nucleic acid |
| 09/29/2004 | EP1461422A1 Interleukin-2 gene transferred lymphokine activated killer cells |
| 09/29/2004 | EP1461421A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 09/29/2004 | EP1461087A1 Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461066A1 The use of il6r/il6 chimera in nerve cell regeneration |
| 09/29/2004 | EP1461059A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 09/29/2004 | EP1461054A2 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 09/29/2004 | EP1461052A2 Nucleic acid injected into hepatic vein lumen and delivered to primate liver |
| 09/29/2004 | EP1461037A2 Beverage treated with nicotine |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1461012A1 Hygiene tissue impregnated with a composition comprising a lactic producing bacterium suspended in a lipid |
| 09/29/2004 | EP1460930A2 Eb matrix production from animal tissue and its use for tissue repair |
| 09/29/2004 | EP1244462B1 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases |
| 09/29/2004 | EP1206267B1 Medicaments containing xenogenic oligo- or/and polyribonucleotides |
| 09/29/2004 | EP1196540B1 Tissue maintaining system |
| 09/29/2004 | EP1023078A4 Precipitation of growth-factor-enriched fibrinogen concentrate from platelet rich plasma |
| 09/29/2004 | EP0983095B1 Peptide-coated implants and methods for producing them |
| 09/29/2004 | EP0983080B1 Synthetic, statistic thymus peptide combination and its use as a preparation with immunological and/or endocrinological effect |
| 09/29/2004 | EP0952824B1 Enteric coating, comprising alginic acid, for an oral preparation |
| 09/29/2004 | CN1533433A Method for virus propagation |
| 09/29/2004 | CN1533431A Methods and reagents for cell transplantation |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533283A Use of osteopontin for treatment and/or prevention of neurologic diseases |
| 09/29/2004 | CN1533280A Carbohydrate modifying agent and drinks containing the same |
| 09/29/2004 | CN1533242A Foot and mouth disease virus vaccine |
| 09/29/2004 | CN1531858A Milk |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168490C Health-care products extracted from ostrich blood, penis orchis |
| 09/29/2004 | CN1168482C Chinese medicine composition for treating enteritis |
| 09/29/2004 | CN1168480C Externally applied ointment for treating burns and its prepn |
| 09/29/2004 | CN1168479C Ointment for curing rheumatism and osteoarthropathy |
| 09/29/2004 | CN1168473C Chines medicine prepn for treating arterioscleriosis |
| 09/29/2004 | CN1168472C Chinese medicine prepn for treating lupus erythematosus |
| 09/29/2004 | CN1168470C Tonic wine for strengthening body's immunological function |
| 09/29/2004 | CN1168467C Medicine for treating syphilis |
| 09/29/2004 | CN1168466C Traditional Chinese medicine for treating osteoporosis |
| 09/29/2004 | CN1168464C Traditional Chinese medicine for treating hepatitis |
| 09/29/2004 | CN1168459C Chinese medicine for treating icterhepatitis |
| 09/29/2004 | CN1168456C Capsule for treating nasosimusitis |
| 09/29/2004 | CN1168455C Low agglutinin universal refrigerated plasma |
| 09/29/2004 | CN1168454C Jusheng oil and preparation process |
| 09/28/2004 | US6797703 Gene therapy using TGF-β |
| 09/28/2004 | US6797702 Methods and compositions comprising DNA damaging agents and P53 |
| 09/28/2004 | US6797514 Simultaneous stimulation and concentration of cells |
| 09/28/2004 | US6797491 Human papilloma virus treatment |
| 09/28/2004 | US6797287 Administering a formulation containing phaseolamin (white kidney bean extract) and a mineral, such as chromium or vanadium or both for controlling carbohydrate cravings |
| 09/28/2004 | US6797276 Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response |
| 09/28/2004 | US6797269 Mesenchymal stem cells as immunosuppressants |
| 09/28/2004 | US6797267 Use of cytokines and mitogens to inhibit pathological immune responses |
| 09/28/2004 | US6797266 Probiotic composition containing Lactobacillus casei strain ATCC PTA-3945 |
| 09/28/2004 | US6797264 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 09/28/2004 | US6796954 Method for preparing leucocyte-free blood preparation and blood administration set |
| 09/23/2004 | WO2004081052A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | WO2004080980A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 09/23/2004 | WO2004080475A1 Composition against infection with rotavirus and process for producing the same |
| 09/23/2004 | WO2004080471A1 A new use for scorpion venom as product for malaria treatment and prophylaxis |
| 09/23/2004 | WO2004080448A2 Use of nep-associated molecules for treating non-immunogenic, non-hypertensive civilisation diseases |
| 09/23/2004 | WO2004080175A2 Scaffold for cell growth and differentiation |
| 09/23/2004 | WO2004069156A3 Inactivated probiotic bacteria and methods of use thereof |
| 09/23/2004 | WO2004067704A3 Freeze-dried fibrin matrices and methods for preparation thereof |
| 09/23/2004 | WO2004035011A3 Botulinum toxin dental therapies and procedures |
| 09/23/2004 | WO2004010852A3 Tissue compositions and methods for producing same |
| 09/23/2004 | WO2003094836A3 Methods and products for enhancing immune responses using imidazoquinoline compounds |
| 09/23/2004 | WO2003068809A8 An herpes simplex virus complex |
| 09/23/2004 | US20040186587 Devices and methods for treating tissue |
| 09/23/2004 | US20040186275 Sarcomere binding polypeptide for use in diagnosis and treatment of diabetes and cardiomyopathies; diuretics; vasodilation; antiarrhythmic agents |
| 09/23/2004 | US20040186059 Method for treating conditions associated with the Metabolic Syndrome (Syndrome X) |
| 09/23/2004 | US20040186050 Method for orally administering parathyroid hormone (pth) |
| 09/23/2004 | US20040186047 Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing |
| 09/23/2004 | US20040185563 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 09/23/2004 | US20040185557 Human linkeage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses |
| 09/23/2004 | US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering |
| 09/23/2004 | US20040185537 Novel fructosyltransferases |
| 09/23/2004 | US20040185524 comprises a solute and dimethylsulfoxide (DMSO) by fluid phase endocytosis to produce an internally loaded biological sample; includes freeze/vaccum drying |
| 09/23/2004 | US20040185508 Methods and reagents for modulating cholesterol levels |
| 09/23/2004 | US20040185166 Hot water extraction, then extracting with acid solution, neutralized to obtain a precipitate zinc; food processing |
| 09/23/2004 | US20040185128 Use of an extract of the root of balloon-flower for preventing and treating a degenerative brain disease or for enhancing memory |
| 09/23/2004 | US20040185115 Preventing herpes, impetigo, psoriasis, seborrheic dermatitis, acne, micromedo, anthrax, and diaper rash; skin cleansing articles; refined sterilized emu oil, benzoin, benzyl alcohol, allantoin, propyl paraben, methyl paraben, and alkyl esters such as methyl p-hydroxybenzoate |
| 09/23/2004 | US20040185088 Absorbent, flexible layer bonded to elastomeric substrate comprising refined sterilized emu oil, aromatic alcohol, benzoic acid, allantoin, methylparaben, alkyl ester, propylparaben, and adhesive |
| 09/23/2004 | US20040185083 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products |
| 09/23/2004 | US20040185046 Methods of treating autoimmune disease via CTLA-4Ig |
| 09/23/2004 | US20040185043 Administering agent that depletes alpha beta -, and gamma delta -TCR+ T cells and/or CD8+ T cells; transplantation with hematopoietic stem cells from donor matched at the major histocompatibility complex class I K locus; grafting |
| 09/23/2004 | US20040185034 anti-inflammatory cytokines, such as IL-4, IL-10 and chemokines, to induce development of suppressor activity in T cells |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | US20040185032 enhanced development of prebiotic gastrointestinal ecology in patients with co-morbid diseases which exhibit problems secondary to impaired gastrointestinal health |
| 09/23/2004 | US20040182795 For separation and concentration of plasma and plasma platelet mixtures from plasma-erythrocyte mixtures such as whole blood and is particularly applicable to the preparation and use of autologous plasma concentrates |
| 09/23/2004 | DE10311984A1 Using neutral endopeptidase-associated molecules for treatment, diagnosis, prophylaxis and monitoring of eating and metabolic disorders and dementia, also for drug development |
| 09/23/2004 | CA2518577A1 Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 09/23/2004 | CA2518549A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalopathies |
| 09/23/2004 | CA2518182A1 Scaffold for cell growth and differentiation |
| 09/22/2004 | EP1460120A1 Anion generating material and skin treating agent using the same |
| 09/22/2004 | EP1459757A1 Immunomodulating polymers |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |